Intriguingly, the present study identified that SLC2A3 is a target gene of miR-184 and is highly expressed in ccRCC tissues and cell, whereas, the down-regulation of SLC2A3 was associated with the ccRCC development. This evidence concerns the gene SLC2A3 and nonpapillary renal cell carcinoma.